Ligand validation:6NH4

BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6NH4_BTB_B_508	50%	66%	0.162	0.913	0.68	0.62	-	-	0	0	100%	1
6NH4_BTB_A_504	42%	72%	0.151	0.871	0.4	0.68	-	-	0	0	100%	1
6NH4_BTB_B_505	42%	62%	0.179	0.897	0.5	0.95	-	1	3	0	100%	1
6NH4_BTB_D_505	37%	66%	0.164	0.863	0.52	0.77	-	-	0	0	100%	1
6NH4_BTB_B_504	36%	70%	0.165	0.858	0.47	0.69	-	-	1	0	100%	1
6NH4_BTB_C_505	31%	84%	0.149	0.818	0.38	0.39	-	-	0	0	100%	1
6NH4_BTB_A_503	18%	60%	0.179	0.768	0.46	1.06	-	1	2	0	100%	1
6NH4_BTB_D_504	16%	62%	0.26	0.829	0.58	0.85	-	-	2	0	100%	1
6PP3_BTB_B_509	82%	66%	0.115	0.972	0.36	0.94	-	1	1	0	100%	1
7TSH_BTB_C_504	82%	67%	0.124	0.981	0.5	0.75	-	-	0	0	100%	1
6NH8_BTB_C_504	82%	76%	0.113	0.967	0.38	0.57	-	-	2	0	100%	1
5VVB_BTB_A_504	77%	77%	0.13	0.97	0.36	0.55	-	-	2	0	100%	1
7TSL_BTB_A_504	77%	60%	0.115	0.954	0.41	1.1	-	-	2	0	100%	1
2OB3_BTB_A_906	98%	13%	0.06	0.986	2.82	1.16	4	1	0	0	100%	1
2OQL_BTB_B_701	95%	63%	0.066	0.969	0.66	0.75	-	-	0	0	100%	1
4WQM_BTB_A_406	94%	34%	0.068	0.966	1.71	0.91	3	-	1	0	100%	1
5O5D_BTB_B_504	94%	66%	0.071	0.969	0.94	0.38	2	-	0	0	100%	1
4AYO_BTB_A_503	92%	53%	0.085	0.977	1.02	0.8	1	-	0	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.